Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
批准号:
8051607
负责人:
MAHENDRA KAVDIA
金额:
$34.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-14 至 2013-11-30
关键词:
AntioxidantsApoptosisBiological AvailabilityBiological ProcessBlood VesselsBlood flowCellsComplexComputer SimulationDataDevelopmentDiabetes MellitusEndothelial CellsEndotheliumEnvironmental Risk FactorEnzymesFeedbackFree Radical FormationFunctional disorderGenerationsGlucoseGoalsHumanHyperglycemiaImpairmentIn VitroKineticsLipid PeroxidationLiteratureMeasurementMeasuresMediatingMicrocirculationModelingMolecularNitratesNitric OxideNitric Oxide SynthaseNitritesOxidative StressPathway interactionsPeroxonitriteProcessProductionReactionReactive Nitrogen SpeciesReactive Oxygen SpeciesRegulationResearchSimulateSuperoxide DismutaseSuperoxidesSystemTestingTimeTissuesUmbilical veinVasodilationabstractingcell injurydesigndiabetes mellitus therapydiabetichuman NOS3 proteinimprovedmulti-scale modelingpreventresearch studyresponseshear stresstherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Endothelial cell (EC) dysfunction is a common pathogenic framework of many of the diabetes-related micro-
and macro- vascular complications. Reduced bioavailability of EC-released nitric oxide (NO) is a primary
marker generally used for EC dysfunction. However, the molecular mechanisms of hyperglycemia induced
reduced NO bioavailability remain poorly understood. [We hypothesize that the diabetic endothelial cell
dysfunction/reduced NO bioavailability is mediated by reactive oxygen species (ROS) and is a results of
increased interaction of NO and superoxide (O2-) at the endothelial cell level. The increased interactions results
in higher peroxynitrite (ONOO-) formation, shifting nitric oxide synthase (eNOS) activity from NO production to
O2¿ production, and EC damage. The deleterious effects can be prevented by reducing ROS formation and
concentration. Specific aims are designed to test these hypotheses. Aim1. Determine the EC release of NO
and O2- and cell damage in hyperglycemic conditions. Hypotheses are: i) the high glucose causes endothelial
dysfunction over long periods by increasing ONOO- and O2- formation and ii) reduction in O2- formation is key
to reducing endothelial dysfunction. We will perform the following experiments: i) determining the effect of high
glucose on eNOS and NA(D)PH expressions, NO and superoxide releases, endothelial cell lipid peroxidation
(an indicator of peroxynitrite formation) and apoptosis in human umbilical vein endothelial cells (HUVECs) over
short and long time-periods, and ii) determining whether increasing NO or decreasing O2- formation will be
effective in preventing effects of high glucose. Aim2. Develop a reaction kinetic-transport computational model
to simulate experiments of Aim1 and predict levels of NO, O2- and ONOO- at EC level. Hypotheses are: i) the
NO concentration is reduced and ONOO- is increased due to high interaction between NO and O2- even though
the NO release from endothelial cell increases in high glucose over short periods and ii) the NO concentration
increases and ONOO- concentration decreases when O2- formation or concentration is reduced in high
glucose. Aim3. Develop a multi-scale computational model for NO, ROS (O2-), and reactive nitrogen species
(RNS; ONOO-) transport in the microcirculation underlying the process of oxidative stress. Hypotheses are: i)
endothelial cell dysfunction is a results of higher superoxide formation, ii) a reduction in ROS formation
enhances NO bioavailability and iii) increased superoxide dismutase levels not only reduces the O2- levels but
also increases the NO levels, and reduces NO formation through feedback mechanism. At EC level, we will
model the regulation of eNOS and the release of NO and O2-. At tissue level, we will model a volume of tissue
containing an arteriolar blood vessel and simulate transport of NO, ROS and RNS.] This combined
experimental & computational approach is critical in our understanding of molecular mechanism of EC
dysfunction and examine the potential therapies to treat EC dysfunction related vascular complications. Project Narrative
Endothelial cell (EC) dysfunction is a common pathogenic framework of many of the diabetes-related micro-
and macro- vascular complications. The molecular mechanisms of hyperglycemia induced endothelial cell
dysfunction remain poorly understood. The proposed research will use integrated computational and
experimental approaches to assess endothelial cell dysfunction caused by oxidative stress due to high glucose
at the molecular, cellular and tissue levels. The integrated experimental measurements and computational
modeling of oxidative stress will provide an optimum set of parameters that will not only improve endothelial
cell dysfunction/NO bioavailability but also will guide us in the development of therapies for diabetes related
vascular complications.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Induced peroxidase and cytoprotective enzyme expressions support adaptation of HUVECs to sustain subsequent H2O2 exposure.
诱导的过氧化物酶和细胞保护酶表达支持 HUVEC 的适应以维持随后的 H2O2 暴露。
DOI:
10.1016/j.mvr.2015.09.003
发表时间:
2016-01
期刊:
Microvascular research
影响因子:
3.1
作者:
[Patel H, Chen J, Kavdia M]
通讯作者:
Kavdia M
DOI:
10.1016/j.freeradbiomed.2011.06.009
发表时间:
2011-10-01
期刊:
Free radical biology & medicine
影响因子:
7.4
作者:
[Kar S, Kavdia M]
通讯作者:
Kavdia M
DOI:
10.2174/1567202611310020011
发表时间:
2013-05
期刊:
Current neurovascular research
影响因子:
2.1
作者:
[Caitlin E Presnell;Gaurav Bhatti;L. Numan;M. Lerche;Salem K Alkhateeb;M. Ghalib;M. Shammaa;M. Kavdia-M.]
通讯作者:
Caitlin E Presnell;Gaurav Bhatti;L. Numan;M. Lerche;Salem K Alkhateeb;M. Ghalib;M. Shammaa;M. Kavdia-M.
DOI:
10.1615/critrevbiomedeng.v39.i5.60
发表时间:
2011
期刊:
Critical reviews in biomedical engineering
影响因子:
--
作者:
[Kavdia,Mahendra]
通讯作者:
Kavdia,Mahendra
Local oxidative and nitrosative stress increases in the microcirculation during leukocytes-endothelial cell interactions.
在白细胞-内皮细胞相互作用期间,微循环中的局部氧化和亚硝化应激增加。
DOI:
10.1371/journal.pone.0038912
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Kar,Saptarshi, Kavdia,Mahendra]
通讯作者:
Kavdia,Mahendra
共 8 条
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:8265529
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:7466966
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:7612754
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
Red Blood Cell Function in Nitric Oxide Biotransport
-
批准号:7456844
-
项目类别:
-
资助金额:$20.78万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:7787434
-
项目类别:
-
资助金额:$9.49万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: